About Mangeet Kaur Bouns

Mangeet’s keen interest in the stock market led her to become an investment researcher and financial journalist. Using her fundamental approach to analyzing stocks, Mangeet’s looks to help retail investors understand the underlying factors before making investment decisions. She earned a bachelor's degree in finance from BI Norwegian Business School.


Recent Articles By Mangeet Kaur Bouns

: AMZN |  News, Ratings, and Charts

3 Top S&P 500 Stocks With Strong Analyst Ratings

The S&P 500 index’s 2024 rally continued in June as solid corporate earnings outweighed concerns over slower economic growth and a potential delay in the Fed’s pivot to interest rate cuts. Further, several Wall Street strategists raised their year-end S&P 500 price targets. Hence, top-performing S&P 500 stocks Amazon.com (AMZN), Salesforce (CRM), and Abbott (ABT) could be ideal buys now. Read more...
: PGR |  News, Ratings, and Charts

3 Momentum Stocks to Ride the Bull Market

Despite persistent fears around high interest rates, the economy continues to perform well thanks to strength in the labor market, steady consumer spending, and strong industrial production. Given bullish market trends, it could be wise to invest in fundamentally sound stocks Progressive Corporation (PGR), Energy Transfer (ET), and Williams Companies (WMB) with solid momentum. Read on...
: CRWD |  News, Ratings, and Charts

Is Now the Perfect Time to Invest in CrowdStrike?

CrowdStrike (CRWD) delivered stellar first-quarter performance, beating analyst estimates on both top and bottom lines. Despite a bright long-term growth outlook supported by solid market demand, strategic initiatives, and robust financial health, the cybersecurity firm faces challenges with regulatory compliance and intense competition. So, let’s find out if it’s the right time to invest in this stock...
: EXPE |  News, Ratings, and Charts

3 Value Stocks With Strong Fundamentals to Buy Now

Value investing is highly favored as it focuses on purchasing undervalued stocks with solid fundamentals, providing the potential for high returns with lower risk and a disciplined, long-term approach. Therefore, it could be wise to invest in fundamentally sound, value stocks Expedia Group (EXPE), Incyte (INCY), and Albertsons Companies (ACI) for substantial long-term returns. Keep reading...
: SMAR |  News, Ratings, and Charts

SMAR (Smartsheet) Earnings Recap: Buy, Hold, or Sell

Smartsheet (SMAR) concluded the fiscal 2025 first quarter on a solid note, demonstrating steady progress throughout the quarter. Further, the company’s long-term outlook appears promising, driven by its strategic initiatives and commitment to delivering innovative solutions that meet evolving customer needs. So, should you buy, hold, or sell this stock post its earnings? Read on...
: GME |  News, Ratings, and Charts

GME (GameStop) Earnings Preview: Can Gaming Sector Momentum Be Sustained?

GameStop’s (GME) preliminary first-quarter 2024 results reveal a drop in net sales and significant losses. The retailer faces challenges from reduced demand for physical games and heightened competition from e-commerce giants. Let’s find out if GME can weather the storm and sustain momentum in the gaming sector. Read more...
: DELL |  News, Ratings, and Charts

Dell Technologies (DELL) Earnings Review: What’s Next for Investors?

While Dell Technologies’ (DELL) revenue topped analyst expectations for the first quarter of fiscal 2025, the company fell short on earnings. Let’s discuss how investors should interpret Dell’s recent financial results and what they should consider moving forward. Read on to know more...
: NVDA |  News, Ratings, and Charts

NVIDIA (NVDA) Earnings Are Out: Here's What to Do

NVIDIA’s (NVDA) much-anticipated first-quarter earnings report comfortably surpassed analyst expectations, driven by massive demand for its AI chips. The chipmaker also announced a 10-to-1 stock split. Following an impressive financial performance, how should investors approach this stock? Read on to know more...
: LLY |  News, Ratings, and Charts

Eli Lilly (LLY) or Pfizer (PFE): Which Stock Can Surge From Earnings?

Amid increasing healthcare spending, breakthroughs in genomics and personalized medicine, and the adoption of new technologies, the pharma industry is booming. So, let’s analyze Eli Lilly (LLY) and Pfizer (PFE) to determine which pharma stock will surge from their first-quarter earnings. Read on to find out...
: OPTN |  News, Ratings, and Charts

3 Pharma Stocks to Snatch up During Market Dips

The pharmaceutical industry is undergoing rapid growth and expansion, driven by rising medical needs, favorable regulatory measures, and the implementation of pharma 4.0. Hence, investors could snatch up quality pharma stocks Bristol-Myers Squibb (BMY), Spero Therapeutics (SPRO), and OptiNose (OPTN) for steady returns during market dips. Read more...
Page generated in 1.3414 seconds.